Trial Profile
Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate; Prednisolone
- Indications Behcet's syndrome; Posterior uveitis; Retinal vascular occlusion
- Focus Therapeutic Use
- 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138901292641N2).
- 20 Jul 2011 New trial record